The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
about
Endocrine causes of nonalcoholic fatty liver diseaseA randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.Molecular basis for the interaction of the mammalian amino acid transporters B0AT1 and B0AT3 with their ancillary protein collectrinStrategies to prevent and reverse liver fibrosis in humans and laboratory animals.Pharmacotherapy for Nonalcoholic Fatty Liver Disease.Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.Renin angiotensin system in liver diseases: Friend or foe?Modulation of angiotensin II signaling in the prevention of fibrosis.Angiotensin II induces connective tissue growth factor expression in human hepatic stellate cells by a transforming growth factor β-independent mechanism.NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet.Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade.Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.Balancing effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R axis and ACE2-Ang-(1-7)-Mas axis in rats with CCl4-induced hepatic fibrosis.Association between ACE2/ACE balance and pneumocyte apoptosis in a porcine model of acute pulmonary thromboembolism with cardiac arrest.Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.Targeting the renin-angiotensin system in liver fibrosis.Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats.Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system
P2860
Q26780254-2E7A0757-DE43-449C-BCF7-F5AA6434E34AQ33574413-B2FAD6B3-11AC-442C-96F6-088DF33B68E4Q35736694-DB33B530-8066-4CA2-A30E-3E0BAAA1C868Q38473640-2231EF54-A337-461F-9175-3F30E9197243Q38588344-908ECAC3-3AE1-4478-BB7D-79AA99CFE0C3Q38879747-407E9981-7D48-4B90-A26A-3D344A8B7C9BQ39134595-CAF29094-D2BA-4D69-B144-F7B79FC48269Q39360840-E25AADB7-9A5E-4DFB-AC41-E3AC5F81AF6AQ40362636-C6B513CC-E371-48E5-9F64-E49EB6090C8DQ41353200-C35C6EF2-095A-465E-A3C9-DEF4FC41C70CQ42072118-55688BDB-1871-4AC4-AAC4-AC09ED8DEB12Q42330055-F2B1DAEA-DD68-4B6C-924E-AB954819DCA9Q42354239-E039169D-DD9C-45C1-BE52-E29F08BBF1AEQ48506246-F1564B64-D059-4A58-9A39-D5CBC4C6190CQ50067734-5086B136-65E0-487B-9087-79EC4C2EE014Q50223405-778B06D6-6AD9-4ED0-930B-433B4D92FEC3Q50238685-C2A2BCB3-094D-4E84-9BAF-855D656F08CFQ50937968-132643D0-0EF9-4C2B-9E3C-42A095E3725EQ55008612-975852BF-53D7-4EF7-90BC-EA28EA72D0C8Q57844928-2BD5A632-BA29-43FA-BEA9-9AC86833D6FB
P2860
The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The role of renin-angiotensin ...... prevention of liver diseases.
@en
type
label
The role of renin-angiotensin ...... prevention of liver diseases.
@en
prefLabel
The role of renin-angiotensin ...... prevention of liver diseases.
@en
P2093
P1433
P1476
The role of renin-angiotensin ...... prevention of liver diseases.
@en
P2093
John David Feltenberger
Simone Moreira de Macêdo
Sérgio Henrique Sousa Santos
Talita Antunes Guimarães
P304
P356
10.1016/J.PEPTIDES.2014.10.005
P577
2014-12-01T00:00:00Z